Anticancer drug design based on plant-derived natural products

Journal of Biomedical Science

Volumn 6, Issue 4, 1999, Pages 236-250

  Lee, Kuo Hsiung ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Anticancer agents; Drug design; Natural products; Synthetic analogs

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; COLCHICINE DERIVATIVE; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; ETOPOSIDE DERIVATIVE; FLAVONOID; GYRASE INHIBITOR; IRINOTECAN; NAPHTHYRIDINE DERIVATIVE; NATURAL PRODUCT; NAVELBINE; PACLITAXEL; TENIPOSIDE; TOPOTECAN; VINBLASTINE; VINBLASTINE SULFATE; VINCRISTINE; VINCRISTINE SULFATE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG RESEARCH; DRUG STRUCTURE; HERBAL MEDICINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0032777463     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253565     Document Type: Review

References (68)

1. Andreu JM, Timasheff SN, Conformational states of tubuling liganded to colchicine, tropolone methyl ether, and podophyllotoxin. Biochemistry 21:6465-6476;1982.
2. Banwell MG, Petters SC, Greenwood RJ, MacKay MF, Hamel E, Lin CM. Semisyntheses. X-ray crystal structures, and tubulinbinding properties of 7-oxodeacetamidocolchicine and 7-oxodeactamidoisocolchincine. Austr J Chem 45:1577-1588;1992.
3. Bastow KF, Tatematsu H, Bori ID, Fukushima Y, Sun L, Goz B, Lee KH. Anitumor agents 140. Induction of reversible protein-linked DNA breaks in human osteogenic sarcoma cells by novel cytocidal colchicine derivatives which inhibit DNA topoisomerase II in vitro: absence of cross-resistance in a colchicineresistant sub-clone. Bioorg Med Chem Lett 3: 1045-1050;1993.
4. Bastow KF, Tatematsu H, Sun L, Fukushima Y, Lee KH. Antitumor agents 146. Synthesis and biological evaluation of tetrademethyl isocolehicine derivatives as inhibitors of DNA topoisomerase action in vitro. Bioorg Med Chem 1:227-234;1993.
5. Bastow KF, Wang HK, Cheng YC, Lee KH. Antitumor agents 173. Synthesis and evaluation of camptothecin-4ß-amino-4'-O-demethyl epipodophyilotoxin conjugates as inhibitors of mammalian NDA topoisomerases and as cytotoxic agents, Bioorg Med Chem 5:1481-1488; 1997.
6. Bhattacharyya B, Howard R, Maity SN, Brossi A, Sharma PN, Wolff J. B ring regulation of colchicine binding kinetics and fluorescence. Proc Natl Acad Sci USA 83:2052-2053;1986.
7. Boyé O, Brossi A. Tropolonic Colchicum alkaloids and allo congeners. In: Brossi A, Cordell GA, eds. The Alkaloids. New York, Academic Press, 41:125-176;1992.
8. Brossi A, Bioactive alkaloids. 4, Results of recent investigations with colchicine and physostigmine. J Med Chem 33:2311-2319;1990.
9. Brossi A, Boyé O, Muzaffar A, Yeh HJ, Toome V, Wegrzynski B, George C. aS, 7S-absolute configuration of natural (-)-colchicine and allocongeners. FEBS Lett 262:5-7;1990.
10. Brossi A, Sharma PN, Atwell L, Jacobson AE. Iorio MA, Molinari M, Chignell CF. Biological effects of modified colchicines. 2, Evaluations of catecholic colchicines, colchifolines. colchicide, and novel N-acyl- and N-aroyldeaeetyl-colchicines. J Med Chem 26:1365-1369;1983.
11. Potmesil M, Pinedo HM, eds. Camptothecins: New Anticancer Agents. Boca Raton, CRC Press, 113-121;1995.
12. Capraro HG, Brossi A, Tropolonic Colchicum alkaloids. In: Brossi A, ed. The Alkaloids New York, Academic Press, 23:1-70;1984.
13. Carrondo MA, Coll M, Ayami J, Wang AH, van der Marel GA, van Boom JH, Rich A. Binding of a Hoechst dye to d(CGCGA-TATCGCG) and its influence on the conformation of the DNA fragment. Biochemistry 28: 7849-7859;1989.
14. Chakrabarti G, Sengupta S, Bhattacharyya B. Thermodynamics of colchicinoid-tubulin interactions. Role of B-ring and C-7 substituent. J Biol Chem 271:2897-2901;1996.
15. Chen K, Kuo SC, Hsieh MC, Mauger A, Lin CM, Hamel E, Lee KH. Antitumor agents 174. 2′,3′,4′,5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones. their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 40:2266-2275;1997.
16. Chen K, Kuo SC, Hsieh MC, Mauger A, Lin CM, Hamel E, Lee KH. Antitumor agents 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4-onesas antitumor agents that inhibit tubulin polymerization. J Med Chem 40:3049-3056;1997.
17. Cheng CC A common structural pattern among many biologically active compounds of natural and synthetic origin. Med Hypotheses 20:157-172;1986.
18. Cho SJ, Kashiwada Y, Bastow KF, Cheng YC, Lee KH. Antitumor agents 164. Podophenazine. 2″,3″-dichloropodophcnazine, benzopodophenazine, and their 4β-ρ-nitroaniline derivatives as novel DNA toposiomerase II inhibitors. J Med Chem 39:1396-1402;1996.
19. Cho SJ, Tropsha A, Suffness M, Cheng YC, Lee KH. Antitumor agents 163. Three-dimensional quantitative structure-activity relationship study of ′O-demethylepipodophyllotoxin analogs using the modified CoMFA/q2-GRS approach. J Med Chem 39:1383-1395;1996.
20. Cragg G, Suffness M, Metabolism of plantderived anticancer agents. Pharmacol Ther 37: 425-461;1988.
21. Issell BF, Muggia FM, Carter SK, eds. Etoposide (VP-16) Current Status and New Developments. Orlando, Academic Press, 1984.
22. Fossell FV, University of Texas MD Anderson Cancer Center and Chen J, Genelabs Technologies. Inc., personal communications.
23. Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Ariyoshi Y, Negoro S, Masuda N, Nakajima S, Taguchi T. A phase II study of CFT-II, a new derivative of camptothecin. for previously untreated nonsmall-cell lung cancer. J Clin Oncol 10:16-20; 1992.
24. Guan J, Zhu XK, Tachibana Y, Bastow KF, Brossi A, Hamel E, Lee KH. Antitumor agents 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogs as novel topoisomerase II inhibitors. J Med Chem 41:1956-1961;1998.
25. Haim N, Nemec J, Roman J. Sinha BK. In vitro metabolism of etoposide (CP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins. Biochem Pharmacol 36:527-536;1987.
26. Hamel E, Lin CM, Plowman J, Wang HK, Lee KH, Paull KD. Antitumor 2,3-dihydro-2-aryl4(1H)-quinazolinone derivatives. Interactions with tubulin. Biochem Pharmacol 51:53-59; 1996.
27. Huang TS, Shu CH, Shih YL, Huang HC, Su YC, Chao Y, Yang WK. Whang-Peng J. Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide. Cancer Lett 110 77-85;1996.
28. Iorio MA. Contraction of the tropolonic ring of colchicine by hydrogen peroxide oxidation. Heteroeycles 22:2207-2211;1984.
29. Itoh Y, Brossi A, Hamel E, Lin CM. 132. Colchicine models: synthesis and binding to tubulin of tetramethoxybiphenyls. Helv Chim Acta 71:1199-1209;1988.
30. Ji Z, Wang HK, Bastow KF, Zhu XK, Cho SJ, Cheng YC, Lee KH, Antitumor agents 177. Design synthesis, and biological evaluation of novel etoposide analogs bearing pyrrolecarboxamidino group as DNA topoisomerase II inhibitors. Bioorg Med Chem Lett 7.607-612;1997.
31. Johnson PK, McCabe FL, Faucette LF, Hertzberg RP, Kingsbury WD, Boehm JC. Caranfa MJ, Holden KG. SK&F 104864, a water-soluble analog of camptothecin with broad spectrum activisty in preclinical tumor models. Proc Am Assoc Cancer Res 30:623;1989.
32. Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K. Intracellular roles of SN-38. a metabolite of the camptothecin derivative CPT-II, in the antitumor effect of CPT-II. Cancer Res 51: 4187-4191;1991.
33. Keller-Juslen C, Kuhn M, von Wartburg A, Stahelin H. Synthesis and antimitotic activity of glycosidie lignan derivatives related to podophyllotoxin. J Med Chem 14:936-940;1971.
34. Kerekes P, Brossi A, Flippen-Anderson JL, Chignell CF. 63. Ethers of 1-O-demethylthio-colchicines: formation of isomers in chloroform solution. Helv Chim Acta 68:571-580; 1985
35. Kuo SC, Lee HZ, Juang JP, Lin YT, Wu TS, Chang JJ, Lednicer D, Paull KD, Lin CM, Hamel E, Lee KH. Synthesis and cytotoxicity of 1.6,7.8-substituted 2-(4′-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin. J Med Chem 36:1146-1156;1993.
36. Lee KH. In: Kinghorn AD. Balandrin M. eds. Human Medicinal Agents from Plants. ACS Symposium Series 534. Washington, American Chemical Society, chapter 12:1993.
37. Lee KH, Imakura Y, Haruna M, Beers SA, Thurston LS. Dal HJ, Chen CH, Liu SY, Cheng YC. Antitumor agents 107. New cytotoxic 4-alkylamíno analogues of 4′-demethylepipodo-phyllotoxin as inhibitors of human DNA topoisomerase II. J Nat Prod 52:606-613;1989.
38. Lee KH, Tagahara K, Suzuki H, Wu RY, Huang HC, Ito K, Iida T, Lai JS. Antitumor agents 49, Tricin. kaempferol-3-O-β-D-glucopyranoside and (+)-nortrachelogenin, antileukemic principles from Wiksiroemia indica. J Nat Prod 44:530-535;1981.
39. Li L, Wang HK, Kuo SC, Lednicer D. Lin CM, Hamel E, Lee KH. Antitumor agents 150. 2′,3′,4′,5′,5,6,7-Substituted 2-phenyl-4-quino-lones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem 37:1126-1135;1994.
40. Li L, Wang HK, Kuo SC, Wu TS, Mauger A, Lin CM, Hamel E, Lee KH. Antitumor agents 155. Synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-qumolones as antimicrotubule agents. J Med Chem 37:3400-3407;1994.
41. MacDonald TL, Lehnert EK, Loper JT, Chow KC, Ross WE. In: Potmesil M, Kohn KW, eds. DNA Topoisomerase in Cancer. New York, Oxford University Press, 119-124; 1991.
42. Mauger A, National Cancer Institute, personal communication.
43. O'Dwyer PJ, Alonso MT, Leyland-Jones B, Marsoni S. Teniposide: a review of 12 years of experience. Cancer Treat Rep 68:1455-1466; 1984.
44. Pjura PE, Grzeskowiak K, Dicherson RE. Binding of Hoechst 33258 to the minor groove of B-DNA. J Mol Biol 197:257-271,1987.
45. Pyles EA, Hastie SB, Effect of the B ring and the C-7 substituent on the kinetics of the colchicinoid-tubulin associations. Biochemistry 32. 2329-2336;1993.
46. Pyles EA, Hastie SB, Conformational analysis of colchicinoids containing an electron-deficient aromatic ring on the B ring. J Org Chem 58:2751-2759;1993.
47. Pyles EA, Rava RP, Hastie SB, Effect of B-ring substituents on absorption and circular dichroic spectra of colchicine analogues. Biochemistry 31:2034-2039;1992.
48. Rösner M, Capraro HG, Jacobson AE, Atwell L, Brossi A, Iorio MA, Williams TH, Sik RH, Chignell CF. Biological effects of modified colchicines. Improved preparation of 2-demethylcolchicine. 3-demethylcolchicine. and (+)-colchicine and reassignment of the position of the double bond in dehydro-7-deacetamidocolchicines. J Med Chem 24:257-261;1981.
49. Sakurai H, Miki T, Imakura Y, Shibuya M, Lee KH. Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds. Mol Pharmacol 40:965-973;1991.
50. Shi Q. Chen K, Chea X, Brossi A, VerdierPinard P, Hamel E, MePhail AT, Tropsha A, Lee KH. Antitumor agents 183. Syntheses, conformational analyses, and antitubuiin activity of allothiocolchicinoids. J Org Chem 63:4018-4025;1998.
51. Shi Q, Chen K, Li L, Chang JJ, Autry C. Kozuka M, Konoshima T, Estes JR, Lin CM, Hamel E, McPhail AT, McPhail DR, Lee KH. Antitumor agents 154. Cytotoxic and antimitotic flavonols from Polanisia dodecandra. J Nat Prod 58:475-482;1995.
52. Shi Q, Chen K, Verdier-Pinard P, Brossi A, Hamel E, McPhail AT, Lee KH. Antitumor agents 184. Syntheses and antitubuiin activity of compounds derived from reaction of thiocolchicone with amines: lactam, alcohol, and ester analogs of allothiocholchicinoids. Helv Chim Acta 81:1023-1037;1998.
53. Shi Q, Verdier-Pinard P, Brossi A, Hamel E, McPhail AT, Lee KH. Antitumor agents 172. Synthesis and biological evaluation of novel deacetamidothiocholchicin-7-ols and ester analogs as antitubuiin agents. J Med Chem 40: 961-966;1997.
54. Sinha BK, Myers CG. Irreversible binding of etoposide (VP-16-213) to deoxyribonucleic acid and proteins. Biochem Pharmacol 33: 3725-3728;1984.
55. Sun L, Hamel E, Lin CM, Hastie SB, Pyluck A, Lee KH. Antitumor agents 141. Synthesis and biological evaluation of novel thiocolchicine analogs: N-acyl-, N-arovl-, and N-(substituted benzyl)deacetylthiocolchicines as potent cytotoxic and antimitotic compounds. J Med Chem 36:1474-1479;1993.
56. Sun L, McPhail AT, Hamel E, Lin CM, Hastic SB, Chang JJ, Lee KH Antitumor agents 139. Synthesis and biological evaluation of thiocolchicine analogs 5.6-dihydro-6(S)-acyloxy- and 5,6 - dihydro - 6(S) - [(aroyloxy) methyl1] - 1,2,3 - trimethoxy - 9 - (methylthio ) - 8H - cyclohepta-[a]naphthalen-8-ones as novel cytotoxic and antimitotic agents. J Med Chem 36:544-551; 1993.
57. Teng M, Usman N, Frederick CA, Wang AH-J, The molecular structure of the complex of Hoechst 33258 and the DNA dodecamer d(CGCGAATTCGCG). Nucleic Acids Res 16: 2671-2690;1988.
58. Vandecandelaere A, Martin SR, Schilstra MJ, Bayley PM, Effects of the tubulin-colchicine complex on microtubule dynamic instability. Biochemistry 33:2792-2801;1994.
59. van Maanen JM, Retel J, deVries J, Pinedo HM. Mechanism of action of antitumor drug eioposide: a review. J Natl Cancer Inst 80: 1526-1533;1988.
60. VePesid Product Information Overview, Bristol Lab., 1983.
61. Wall ME. Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. Plant antitumor agents. I. The isolation and structure of camptothecin. a novel alkaloidal leukemia and tumor inhibitor from Campioiheca acuminata. J Am Chem Soc 88:3888-3890;1966.
62. Wang HK, Liu SY, Hwang KM, Taylor G. Lee KH. Antitumor agents 153. Synthesis of novel water-soluble 7-(aminoacylhydroazono)-formyl camptothecins with potent inhibition of DNA topoisomerase I. Bioorg Med Chem 2: 1397-1403;1994.
63. Wang ZW, Kuo YH, Schnur D, Bowen JP, Liu SY, Han FS, Chang JY, Cheng YC, Lee KH. Antitumor agents 113, New 4ß-arylamino derivatives of 4′-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II. J Med Chem 33:2660-2666;1990.
64. Wani MC, Nicholas AW. Wall ME, Plant antitumor agents 23, Synthesis and antileukemic activity of camptothecin analogues. J Med Chem 29:2358-2363;1986.
65. Xia Y, Yang ZY, Xia P, Bastow K, Tachibana Y, Kuo SC, Hamel E, Hackl T, Lee KH. Antitumor agents 181. Synthesis and biological evaluation of 5,7,2′,3′,4′-substituted- 1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic agents. J Med Chem 41:1155-1162. 1998.
66. Yale HL, Kalkstein M, Substituted 2,3-dihydro-4(1H) quinazolinones, a new class of inhibitors of cell multiplication. J Med Chem 10: 334-336;1967.
67. Zhou XM, Lee KJH, Cheng J, Wu SS, Chen HX, Guo X, Cheng YC, Lee KH. Antitumor agents 144. New γ-lactone ring-modified etoposide analogs as inhibitors of human DNA topoisomerase II. J Med Chem 37:287-292; 1994.
68. Zhu XK, Guan J, Tachibana Y, Bastow KF, Cho SJ, Cheng HH, Cheng YC, Gurwith M, Lee KH. Antitumor agents 194. Synthesis and biological evaluation of 4β-mono-, di-, and trisubstituted aniline-4′-O-demcthyl-podophyllotoxins and related compounds with improved pharmacological profiles. J Med Chem, in press.